Literature DB >> 1680287

Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.

C D Bottema1, R P Ketterling, S Ii, H S Yoon, J A Phillips, S S Sommer.   

Abstract

We report 31 point mutations in the factor IX gene and explore the relationship between the level of evolutionary conservation of an amino acid and the probability of a mutation causing hemophilia B. From our total sample of 125 hemophiliacs and from those reported by others, we identify 95 independent missense mutations, 94 of which occur at amino acids that are evolutionarily conserved in the available mammalian factor IX sequences. The likelihood of a missense mutation causing hemophilia B depends on whether the residue is also conserved in the factor IX-related proteases: factor VII, factor X, and protein C. Most of the possible missense mutations in generically conserved residues (i.e., those conserved in factor IX and in all the related proteases) should cause disease. In contrast, missense mutations in factor IX-specific residues (i.e., those conserved in human, cow, dog, and mouse factor IX but not in the related proteases) are sixfold less likely to cause disease. Missense mutations at nonconserved residues are 33-fold less likely to cause disease. At least three models are compatible with these observations. A comparison of sequence alignments from four and nine species of factor IX and an examination of the missense mutations occurring at CpG residues suggest a model in which most residues fall on opposite ends of a spectrum. In about 40% of residues, virtually any missense mutation in a minority of the residues will cause disease, while virtually no missense mutations will cause disease in most of the remaining residues. Thus, many of the residues in factor IX are spacers; that is, the main chains are presumably necessary to keep other amino acid interactions in register, but the nature of the side chain is unimportant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680287      PMCID: PMC1683179     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  37 in total

1.  AMINO-ACID SEQUENCE INVESTIGATIONS OF FIBRINOPEPTIDES FROM VARIOUS MAMMALS: EVOLUTIONARY IMPLICATIONS.

Authors:  R F DOOLITTLE; B BLOMBAECK
Journal:  Nature       Date:  1964-04-11       Impact factor: 49.962

2.  Comparative sequence analysis of mammalian factor IX promoters.

Authors:  C P Pang; M Crossley; G Kent; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

3.  Evidence that descendants of three founders constitute about 25% of hemophilia B in the United States.

Authors:  R P Ketterling; C D Bottema; J A Phillips; S S Sommer
Journal:  Genomics       Date:  1991-08       Impact factor: 5.736

4.  Haemophilia B: database of point mutations and short additions and deletions.

Authors:  F Giannelli; P M Green; K A High; J N Lozier; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

5.  "Founder" effect in different families with haemophilia B mutation.

Authors:  A R Thompson; S P Bajaj; S H Chen; R T MacGillivray
Journal:  Lancet       Date:  1990-02-17       Impact factor: 79.321

6.  Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.

Authors:  D D Koeberl; C D Bottema; R P Ketterling; P J Bridge; D P Lillicrap; S S Sommer
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

7.  The pattern of factor IX germ-line mutation in Asians is similar to that of Caucasians.

Authors:  C D Bottema; R P Ketterling; H S Yoon; S S Sommer
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

8.  Bovine factor VII. Its purification and complete amino acid sequence.

Authors:  H Takeya; S Kawabata; K Nakagawa; Y Yamamichi; T Miyata; S Iwanaga; T Takao; Y Shimonishi
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

9.  Characterization of a cDNA coding for human factor VII.

Authors:  F S Hagen; C L Gray; P O'Hara; F J Grant; G C Saari; R G Woodbury; C E Hart; M Insley; W Kisiel; K Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX.

Authors:  D J Rees; I M Jones; P A Handford; S J Walter; M P Esnouf; K J Smith; G G Brownlee
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  19 in total

1.  Haemophilia B: database of point mutations and short additions and deletions--third edition, 1992.

Authors:  F Giannelli; P M Green; K A High; S Sommer; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

2.  Missense mutations and the magnitude of functional deficit: the example of factor IX.

Authors:  S S Sommer; E J Bowie; R P Ketterling; C D Bottema
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

3.  An excess of G over C nucleotides in mutagenesis of human genetic diseases.

Authors:  Li Xiao; Wanping Sun; Jia Zhang; Yanping Zhou; Linling Chen; Hanlin Gao; Pierre Sirois; Kai Li
Journal:  Mol Biotechnol       Date:  2011-05       Impact factor: 2.695

4.  Determinants of the factor IX mutational spectrum in haemophilia B: an analysis of missense mutations using a multi-domain molecular model of the activated protein.

Authors:  A I Wacey; M Krawczak; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

5.  From molecular variant to disease: initial steps in evaluating the association of transthyretin M119 with disease.

Authors:  S Ii; J L Sobell; S S Sommer
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

6.  X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.

Authors:  H Brandstetter; M Bauer; R Huber; P Lollar; W Bode
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

7.  The rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX gene.

Authors:  R P Ketterling; E Vielhaber; S S Sommer
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

8.  Haemophilia B: database of point mutations and short additions and deletions--fourth edition, 1993.

Authors:  F Giannelli; P M Green; K A High; S Sommer; M C Poon; M Ludwig; R Schwaab; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1993-07-01       Impact factor: 16.971

9.  The rates and patterns of deletions in the human factor IX gene.

Authors:  R P Ketterling; E L Vielhaber; T J Lind; E C Thorland; S S Sommer
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

10.  Recurrent mutations in the factor IX gene: founder effect or repeat de novo events. Investigation of the German haemophilia B population and review of de novo mutations.

Authors:  O Knobloch; B Zoll; K Zerres; H H Brackmann; K Olek; M Ludwig
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.